CClinicalTrials.gg
CompletedNCT02941471Updated Oct 21, 2016

Transabdominal Electrical Stimulation for Constipation

A Phase 1 interventional study of Interferential Stimulation and TENS stimulation in Constipation, sponsored by St Mark's Hospital Foundation. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-21.

Sponsored by St Mark's Hospital Foundation · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Several transabdominal electrical stimulation studies have been reported for constipation in childhood. This study aims to assess the efficacy of this technique in adults with chronic constipation and compare two different electrical therapies.

Read the detailed description

Patients with Rome III defined constipation unresponsive to medical and behavioural treatment will be randomised in a double-blind prospective trial to receive either four weeks of transabdominal electrical stimulation (TENS) or Interferential stimulation (IFC). Treatment will be self-administered at home for sixty minutes a day. The response to treatment will be assessed with the Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL), the Patient-Assessment of Constipation Symptoms (PAC-SYM) tool and a bowel visual analogue scale (VAS). A bowel diary will be kept a week before and during the final week of stimulation, recording daily bowel frequency.

IFC stimulation is an effective, cheap and low risk intervention which has demonstrated efficacy for dysphagia, urinary incontinence, overactive bladder syndromes and chronic pain. The precise mechanism of its analgesic and pro-kinetic effect is unknown. The intervention is delivered by two separate continuous alternating electrical currents. Two pairs of pad electrodes are arranged in a quadripolar manner where each pair delivers a different frequency of current. It is suggested that this arrangement of stimulation improves colonic propagation. However as direct massage of the abdomen has demonstrated benefit in constipation it is argued that IFC is not a specific requirement and that non-IFC electrical stimulation over the abdomen is sufficient to evoke the same colonic and clinical responses. Owing to these questions the efficacy of this intervention will be further evaluated in adults.

This study has two aims. The primary aim is to evaluate the effectiveness of transabdominal electrical nerve stimulation (TENS) in adult patients with chronic constipation. The secondary aim is to establish whether IFC was superior to non-IFC (TENS) electrical stimulation in adults with chronic constipation.

02

Conditions studied

  • Constipation

Browse trials for

Keywords

  • Constipation
  • Neuromodulation
  • Interferential
  • Transabdominal
03

In context

Constipation

1,018 studies on the registry are indexed under Constipation; 139 are open to participants now.

This study's enrollment of 14 is below the median of 80 across 850 interventional studies indexed under Constipation.

Browse Constipation studies →

Lead sponsor

St Mark's Hospital Foundation is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age over 18 years
  • Rome III defined constipation (frequency of defecation of less than three times a week, straining or sense of incomplete emptying associated with at least 25% of defecations. Lumpy, hard stools or anal digitation for at least 25% of defecations
  • Failed Biofeedback
  • Competent and willing to complete stimulation at home
  • Competent and willing to complete the questionnaires and bowel diaries

Exclusion criteria

Exclusion Criteria:

  • Rectal prolapse
  • Active inflammatory bowel disease
  • Pregnancy or intention to become pregnant during trial
  • Spinal cord injuries/cauda equina syndrome
  • Other implanted electrical devices
  • Allergy to device components
  • Neurological disorders
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Interferential Stimulation

    Medical Device: Interferential stimulation. Stimulation parameters: 4 KHz of carrier stimulation, beat frequency between 80-160Hz, amplitude upto 33mA. Delivered via two 100mm x 50mm adhesive pads placed on the anterior abdominal wall

    Device: Interferential Stimulation

  • Active comparator
    Standard electrical stimulation

    Medical Device: Standard electrical stimulation. Parameters set to provide continuous electrical stimulation at a pulse width of 210µs and a frequency of 14Hz and an amplitude upto 33mA.

    Device: TENS stimulation

Interventions

  • DeviceInterferential Stimulation

    Transabdominal interferential electrcial stimulation

    Also known as: NeuroTrac® IFC Rehab device (Verity Medical Ltd, UK).

  • DeviceTENS stimulation

    Transabdominal standard electrical stimulation

    Also known as: NeuroTrac® Continence device (Verity Medical Ltd, UK).

06

What researchers measure

Primary outcomes

  1. Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL)

    A validated tool for constipation severity assessment

    Time frame: After 4 weeks of stimulation

Secondary outcomes

  1. Patient-Assessment of Constipation Symptoms (PAC-SYM)

    A validated tool for constipation severity assessment

    Time frame: After 4 weeks of stimulation

  2. A bowel visual analogue scale

    a bowel visual analogue scale (0-100 where 0= 'very unhappy' 100= 'very happy') based on patients' response to the question 'how happy are you with the way your bowel has been functioning'

    Time frame: After 4 weeks of stimulation

  3. Weekly bowel and laxative diary

    Standard bowel and laxative diary

    Time frame: one week and 4 weeks of stimulation

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02941471
Lead sponsor
St Mark's Hospital Foundation
Responsible party
Fareed Iqbal (Clinical Research Fellow/PI, St Mark's Hospital Foundation) — Principal investigator
First posted
Oct 21, 2016
Start date
Jan 2015
Primary completion
Sep 2015
Completion
Nov 2015
Last update
Oct 21, 2016

Study contacts

Alan Warnes, PhD
study chair · The London Northwest Healthcare NHS Trust

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion